STAT

HHS opens door to possibility of importing some drugs to drive down prices

In an early but striking move, the Trump administration is opening the door to possibility of importing drugs in limited cases.
Secretary of Health and Human Services Alex Azar

WASHINGTON — The Trump administration is opening up the door to importing prescription drugs — at least in a limited number of cases.

The administration said Thursday that the Department of Health and Human Services will form a working group to look at the idea of in cases in which there is a dramatic price increase for a drug produced by one manufacturer and not protected by patents

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
STAT1 min read
Genetic Variant Common Among West African Descendants Contributes To Large Cardiovascular Disease Burden
A new study in JAMA identifies a genetic variant commonly found in people of West African descent that raises a type of cardiovascular disease risk.
STAT1 min read
STAT+: Pharmalittle: We’re Watching BIO Layoffs, AstraZeneca Plans To Double Revenue, And More
The Biotechnology Innovation Organization on Monday announced 30 layoffs that are part of a restructuring.

Related Books & Audiobooks